-
December 8, 2017 •
News •
Jasmina •
Comments (0)
Leading biotherapeutics company CSL Limited has officially opened a new $230 million advanced manufacturing facility in Melbourne’s north, Located at its Behring site in Broadmeadows, the facility will be constructed over two modules, with yesterday’s
-
June 14, 2017 •
News •
Jasmina •
Comments (0)
Australian biotech firm CSL has agreed to acquire an 80% stake in China’s plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (Ruide) in a deal valued at US$352 million. CSL will acquire the package from Humanwell Healthcare Group, which
-
August 14, 2015 •
News •
Jasmina •
Comments (0)
More than 200 CSL workers and AMWU members gathered outside the main Victorian plant on Tuesday to protest against the company’s decision to cut conditions and allowances despite its stunning $1.89 billion profit in the past year, which was revealed to the
-
August 5, 2015 •
News •
Jasmina •
Comments (0)
Australian pharmaceutical giant CSL has completed the US $275 million acquisition of Novartis‘ influenza business. The transaction will see CSL combine the influenza vaccines division with its subsidiary, bioCSL, to create the number two global player
-
July 31, 2015 •
Events •
John •
Comments (1)
Jim Glover of Complete Lean Solutions (CLS) collected a Shingo Award – the Nobel Prize of Manufacturing – on behalf of Victorian printers Vistaprint in Utah last month. Founded by Shigeo Shingo, the Shingo Prize recognises companies for delivering world
-
June 16, 2015 •
News •
Jasmina •
Comments (0)
Australia’s largest biotechnology company, CSL, has urged the Federal Government to consider a more competitive corporate tax environment, such as an advanced manufacturing tax directed at new investment. According to CSL, a more competitive corporate tax
-
October 28, 2014 •
News •
Jasmina •
Comments (0)
CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational Novartis for US $275 million (AUD 312 million). According to the Sydney Morning Herald, the company will
